SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-23-039585
Filing Date
2023-11-06
Accepted
2023-11-06 17:21:33
Documents
3
Period of Report
2023-11-06

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 220038
2 proxy_001.jpg GRAPHIC 228910
3 proxy_002.jpg GRAPHIC 180744
  Complete submission text file 0001493152-23-039585.txt   785714
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40023 | Film No.: 231380829
SIC: 2834 Pharmaceutical Preparations